Global incidence of pertussis after the COVID-19 pandemic
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F75010330%3A_____%2F25%3A00015120" target="_blank" >RIV/75010330:_____/25:00015120 - isvavai.cz</a>
Result on the web
<a href="https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2842103" target="_blank" >https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2842103</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1001/jamanetworkopen.2025.45963" target="_blank" >10.1001/jamanetworkopen.2025.45963</a>
Alternative languages
Result language
angličtina
Original language name
Global incidence of pertussis after the COVID-19 pandemic
Original language description
Importance Pertussis, or whooping cough, is caused by the Bordetella pertussis bacterium. It induces prolonged cough in all age groups and is a severe, life-threatening disease in young infants. Observations In an online workshop organized by the International Bordetella Society on November 12, 2024, most participating countries reported very low pertussis incidence during and immediately following the COVID-19 pandemic. Since that time, many countries have seen large outbreaks of pertussis, particularly in adolescents. Before the pandemic, several countries, especially those using acellular pertussis vaccine in infants, reported circulating B pertussis isolates that lacked the acellular vaccine antigen pertactin. However, most recent isolates have been found to express this antigen. A rise in macrolide-resistant B pertussis isolates was also reported by several countries. Conclusions and Relevance The potential for large outbreaks of pertussis highlights the importance of maintaining or increasing vaccine coverage in pregnancy and in infants and children. The data presented herein suggest a need for new pertussis vaccines that protect against both disease and infection and that reduce transmission.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30302 - Epidemiology
Result continuities
Project
—
Continuities
V - Vyzkumna aktivita podporovana z jinych verejnych zdroju
Others
Publication year
2025
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
JAMA Network Open
ISSN
2574-3805
e-ISSN
2574-3805
Volume of the periodical
8
Issue of the periodical within the volume
12
Country of publishing house
US - UNITED STATES
Number of pages
12
Pages from-to
e2545963
UT code for WoS article
001631834200006
EID of the result in the Scopus database
2-s2.0-105023453553